Literature DB >> 25933278

Opioid substitution therapy-time to replace the term.

Jeffrey H Samet1, David A Fiellin2.   

Abstract

Mesh:

Year:  2015        PMID: 25933278     DOI: 10.1016/S0140-6736(15)60750-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  In the Clinic. Alcohol Use.

Authors:  E Jennifer Edelman; David A Fiellin
Journal:  Ann Intern Med       Date:  2016-01-05       Impact factor: 25.391

Review 2.  Global opioid agonist treatment: a review of clinical practices by country.

Authors:  Harry Jin; Brandon D L Marshall; Louisa Degenhardt; John Strang; Matt Hickman; David A Fiellin; Robert Ali; Julie Bruneau; Sarah Larney
Journal:  Addiction       Date:  2020-05-19       Impact factor: 6.526

3.  The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.

Authors:  Emanuel Krebs; Darren Urada; Elizabeth Evans; David Huang; Yih-Ing Hser; Bohdan Nosyk
Journal:  Addiction       Date:  2017-02-06       Impact factor: 6.526

4.  The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs.

Authors:  Jemima A Frimpong; Karen Shiu-Yee; Thomas D'Aunno
Journal:  Health Serv Res       Date:  2016-09-12       Impact factor: 3.402

5.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

6.  The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.

Authors:  Martha J Bojko; Alyona Mazhnaya; Ruthanne Marcus; Iuliia Makarenko; Zahedul Islam; Sergey Filippovych; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-03-24

7.  Opioid substitution treatment is linked to reduced risk of death in opioid use disorder.

Authors:  Ajay Manhapra; Robert Rosenheck; David A Fiellin
Journal:  BMJ       Date:  2017-04-26

8.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22

9.  Patient engagement, treatment preferences and shared decision-making in the treatment of opioid use disorder in adults: a scoping review protocol.

Authors:  Tyler Marshall; Elizabeth N Kinnard; Myles Hancock; Susanne King-Jones; Karin Olson; Adam Abba-Aji; Katherine Rittenbach; Sunita Vohra
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.